Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine.
Gardiner
S J
SJ
Begg
E J
EJ
Barclay
M L
ML
Kirkpatrick
C M
CM
D000818:Animals; D001379:Azathioprine / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D011110:Polymorphism, Genetic / Q000235:genetics*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D001379:Azathioprine